BMRN Competitors & Alternatives
Compare Biomarin Pharmaceutical Inc with similar stocks in the same industry
Biotechnology
BMRN
Main Stock$59.65
Tradestie Score
56
Market Cap
$10.53B
P/E Ratio
43.2
Revenue Growth
0.0%
Analyst Upside
+47.4%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$241.07
|
$12.36B | 28.1 | 54 | Compare |
|
EXEL
Exelixis Inc
|
$55.54
|
$11.09B | 17.6 | 47 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$33.60
|
$10.76B | - | 56 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$55.98
|
$10.74B | - | 51 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$53.92
|
$10.49B | - | 59 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$80.04
|
$10.22B | - | 56 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$494.27
|
$10.01B | - | 56 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.10
|
$9.33B | 103.0 | 51 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$109.77
|
$8.88B | 254.4 | 61 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$82.07
|
$8.77B | 29.0 | 58 | Compare |
More BMRN Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry